Bioinova is a Czech biotechnology company specializing in the research and development of innovative stem cell-based therapies, particularly in the field of regenerative medicine. The company operates under stringent Good Manufacturing Practice (GMP) standards, ensuring that all products are manufactured in sterile conditions, with rigorous sterility and quality control measures in place. Bioinova's focus includes the development of autologous and allogeneic mesenchymal stem cell therapies, which are designed for various clinical applications such as orthopedic, neurological, and wound healing treatments. Their proprietary storage solutions, BiCureSol® and BiCureChill, facilitate the safe transport and long-term cryopreservation of stem cells, maintaining cell viability and functionality for clinical use.

In addition to their cell therapy products, Bioinova is actively engaged in conducting clinical trials to evaluate the safety and efficacy of their therapies. They have undertaken multiple studies, including the use of autologous bone marrow-derived mesenchymal stem cells for treating knee cartilage defects and employing non-thermal plasma for wound healing. The company is also exploring the potential of non-cellular biological materials to enhance the effects of stem cell therapies. Through these innovative approaches, Bioinova aims to advance the field of regenerative medicine and improve patient outcomes across various medical conditions.

Czechia (Czech Republic)

Production of therapeutically acting cell lines (somatocellular therapy) under the GMP regulations, FDF - final dosage forms, project management and development in GMP. Currently running and/or preparing multiple clinical trials with mesenchymal stem cells. Contractual manufacturing GMP.

Czech biotechnology company primarily dedicated to research and development of novel stem cell-based therapies

Bioinova

Company Details